WEBVTT - RSV: The Quest for a New Vaccine

0:00:03.840 --> 0:00:04.600
<v Speaker 1>What's RSV?

0:00:05.400 --> 0:00:05.600
<v Speaker 2>Yeah?

0:00:06.559 --> 0:00:12.760
<v Speaker 3>What is RSV? Indeed RSV respiratory sensicial virus. To a

0:00:12.800 --> 0:00:15.120
<v Speaker 3>lot of us, it's just a nasty cold, a.

0:00:15.160 --> 0:00:20.680
<v Speaker 1>Nasty cold, and a weird name, right, sensicial, sensicial, sensicial.

0:00:21.000 --> 0:00:22.840
<v Speaker 3>It's not that hard if you don't look at the word.

0:00:24.560 --> 0:00:28.920
<v Speaker 1>Respiratory sensicial virus is super common. We've all had it.

0:00:29.360 --> 0:00:31.600
<v Speaker 1>Sometimes we don't even know we have it, but it

0:00:31.600 --> 0:00:36.000
<v Speaker 1>can make babies and the elderly really really sick. Researchers

0:00:36.040 --> 0:00:40.160
<v Speaker 1>struggled for decades to develop vaccines for RSV, and as

0:00:40.200 --> 0:00:47.199
<v Speaker 1>of this year, we finally have them. I'm Jacob Goldstein,

0:00:47.280 --> 0:00:50.760
<v Speaker 1>and you're listening to Incubation on today's show. We're talking

0:00:50.840 --> 0:00:55.279
<v Speaker 1>about RSV, specifically the long search for a vaccine that

0:00:55.320 --> 0:00:58.080
<v Speaker 1>can protect those who are most vulnerable to the virus

0:00:58.440 --> 0:01:01.560
<v Speaker 1>and maybe the rest of us is well. Well, here

0:01:01.600 --> 0:01:04.479
<v Speaker 1>from two scientists who spent their careers trying to solve

0:01:04.520 --> 0:01:07.679
<v Speaker 1>the surprisingly difficult puzzle of how to develop a vaccine

0:01:07.720 --> 0:01:11.319
<v Speaker 1>for RSV, and well hear how in solving that puzzle,

0:01:11.600 --> 0:01:14.000
<v Speaker 1>they may have also helped to create a powerful new

0:01:14.040 --> 0:01:18.600
<v Speaker 1>way to develop vaccines for loss of diseases. But before

0:01:18.640 --> 0:01:20.680
<v Speaker 1>we get to the story of the vaccine, I wanted

0:01:20.680 --> 0:01:23.320
<v Speaker 1>to learn a little bit about RSV itself and the

0:01:23.440 --> 0:01:26.280
<v Speaker 1>damage it can do. So I called up Karen Landman.

0:01:26.680 --> 0:01:29.840
<v Speaker 1>She's an infectious disease doctor and an epidemiologist, and she

0:01:29.880 --> 0:01:35.800
<v Speaker 1>also writes for vox. So what happens when a baby

0:01:35.880 --> 0:01:39.000
<v Speaker 1>or an old person with a weak immune system gets RSV?

0:01:40.000 --> 0:01:45.080
<v Speaker 3>So the virus infects cells in the respiratory tract. And ideally,

0:01:45.120 --> 0:01:50.080
<v Speaker 3>what happens when your body gets infected by a virus

0:01:50.360 --> 0:01:54.320
<v Speaker 3>is that your body mounts what's called a cytotoxic response.

0:01:54.720 --> 0:01:58.720
<v Speaker 3>It deploys various soldiers from its immune system to go

0:01:58.760 --> 0:02:02.000
<v Speaker 3>and kill the cells that have gotten infected by this virus.

0:02:02.200 --> 0:02:04.640
<v Speaker 3>That's a little bit different from some of the other

0:02:04.880 --> 0:02:07.960
<v Speaker 3>things that the immune system does, like cite A. Toxic

0:02:08.000 --> 0:02:12.280
<v Speaker 3>responses really go in and murder, like they go in

0:02:12.320 --> 0:02:15.080
<v Speaker 3>and explode the cell or they fully eat the cell.

0:02:15.400 --> 0:02:17.320
<v Speaker 3>And it's a different part of the immune system.

0:02:17.400 --> 0:02:18.919
<v Speaker 1>Okay, And why is that important?

0:02:19.160 --> 0:02:22.400
<v Speaker 3>Well, because that section of the immune system is not

0:02:23.160 --> 0:02:27.040
<v Speaker 3>developed yet in newborn babies h and it's waning in

0:02:27.160 --> 0:02:32.320
<v Speaker 3>older adults. So you have cells that are getting infected

0:02:32.320 --> 0:02:35.760
<v Speaker 3>by viruses and that are dying right where they stand,

0:02:35.840 --> 0:02:38.640
<v Speaker 3>sort of in the respiratory tract. And when we talk

0:02:38.680 --> 0:02:41.200
<v Speaker 3>about the respiratory track, this is a very complex kind

0:02:41.280 --> 0:02:44.040
<v Speaker 3>of upside down tree that runs all the way from

0:02:44.040 --> 0:02:45.959
<v Speaker 3>the nose and mouth down to the very bottom of

0:02:46.000 --> 0:02:48.560
<v Speaker 3>the lungs and at the parts of the lungs that

0:02:48.639 --> 0:02:53.240
<v Speaker 3>connect to your trachea, they're pretty narrow. So the narrower

0:02:53.240 --> 0:02:55.919
<v Speaker 3>those tubes are, the easier it is to clog them.

0:02:56.240 --> 0:03:00.920
<v Speaker 3>When this debris accumulates, and baby's chest wall a weaker,

0:03:00.960 --> 0:03:04.400
<v Speaker 3>they're bendy, they're not as good as adults chest walls

0:03:04.440 --> 0:03:07.240
<v Speaker 3>are at hacking up the stuff that's in there. So

0:03:07.320 --> 0:03:09.440
<v Speaker 3>put all of this together, and you have a situation

0:03:09.760 --> 0:03:13.240
<v Speaker 3>where you have a lot of junk clogging up the

0:03:13.280 --> 0:03:16.080
<v Speaker 3>airways and the lungs, making it difficult for air to

0:03:16.120 --> 0:03:19.239
<v Speaker 3>move through the spaces that it normally would move.

0:03:19.160 --> 0:03:21.200
<v Speaker 1>Through, meaning it's hard to breathe.

0:03:21.240 --> 0:03:23.040
<v Speaker 3>It's really hard to breathe in that situation.

0:03:23.120 --> 0:03:27.079
<v Speaker 1>Absolutely obviously a very bad situation. What happens, how do

0:03:27.120 --> 0:03:27.919
<v Speaker 1>you treat that person?

0:03:28.680 --> 0:03:31.720
<v Speaker 3>So they wind up in the hospital. Sometimes you'll see

0:03:31.720 --> 0:03:33.920
<v Speaker 3>them first in the emergency room, and you know the

0:03:34.000 --> 0:03:37.080
<v Speaker 3>sounds are I won't say unmistakable, but the disease is

0:03:37.120 --> 0:03:40.000
<v Speaker 3>so severe, and the babies who have it, they make

0:03:40.040 --> 0:03:43.119
<v Speaker 3>such awful sounds when they have these infections. And you'll

0:03:43.160 --> 0:03:45.520
<v Speaker 3>see also, it's not just the sounds they make, it's

0:03:45.520 --> 0:03:48.280
<v Speaker 3>the way they look. So you'll see their chests kind

0:03:48.320 --> 0:03:51.600
<v Speaker 3>of cave in with every breath they're trying to take

0:03:51.640 --> 0:03:54.000
<v Speaker 3>as they're sucking hard on the air around them and

0:03:54.280 --> 0:03:55.440
<v Speaker 3>failing to get enough in.

0:03:55.720 --> 0:04:00.000
<v Speaker 1>So, if we zoom out on a national or global scale,

0:04:00.360 --> 0:04:03.600
<v Speaker 1>like what is the impact quantitatively of RSV?

0:04:04.560 --> 0:04:09.119
<v Speaker 3>We see around sixty thousand hospitalizations and kids under five

0:04:09.640 --> 0:04:12.720
<v Speaker 3>and around one hundred and twenty thousand hospitalizations and adults

0:04:12.760 --> 0:04:17.200
<v Speaker 3>over sixty five every year, and we see anywhere between

0:04:17.200 --> 0:04:20.080
<v Speaker 3>one hundred and three hundred deaths in kids and around

0:04:20.120 --> 0:04:24.600
<v Speaker 3>fourteen thousand deaths in adults every year in the US alone,

0:04:24.720 --> 0:04:25.880
<v Speaker 3>in the US alone.

0:04:26.000 --> 0:04:28.920
<v Speaker 1>And I understand that the infections, the RSV infections, come

0:04:28.920 --> 0:04:31.640
<v Speaker 1>in waves. So when there is one of these waves,

0:04:31.680 --> 0:04:32.960
<v Speaker 1>what's it like in the hospital?

0:04:33.320 --> 0:04:37.600
<v Speaker 3>Oh, in the hospital, it's like beds in hallways, It's

0:04:37.760 --> 0:04:41.240
<v Speaker 3>like not enough nurses and doctors to take care of

0:04:41.279 --> 0:04:44.680
<v Speaker 3>the number of people they're seeing. And not enough respiratory

0:04:44.720 --> 0:04:47.560
<v Speaker 3>therapists to go around and get people on oxygen and

0:04:47.920 --> 0:04:49.480
<v Speaker 3>get people intubated.

0:04:49.720 --> 0:04:53.159
<v Speaker 1>I mean, that's it's kind of amazing, right that there

0:04:53.240 --> 0:04:56.880
<v Speaker 1>is this huge problem within the hospital of so many

0:04:56.920 --> 0:04:59.640
<v Speaker 1>people who basically can't breathe or need help to breathe

0:04:59.680 --> 0:05:02.479
<v Speaker 1>because they're sick with RSV. I never knew that.

0:05:03.000 --> 0:05:06.279
<v Speaker 3>Yeah, Oh, RSV season is something that really in any

0:05:06.360 --> 0:05:12.919
<v Speaker 3>medical profession you learn to fear. You learn to fear

0:05:12.960 --> 0:05:16.200
<v Speaker 3>the season because you know it's just gonna be long

0:05:16.400 --> 0:05:19.919
<v Speaker 3>days and longer nights of many, many very sick people

0:05:19.920 --> 0:05:23.160
<v Speaker 3>coming to the hospital. You know, tons of babies with RSV,

0:05:24.520 --> 0:05:27.479
<v Speaker 3>some really really sick kids, and uh and tons of

0:05:27.520 --> 0:05:29.960
<v Speaker 3>really worried parents. It's a really tough time of year.

0:05:30.320 --> 0:05:33.520
<v Speaker 3>And it always felt like there was no hope, you know,

0:05:33.680 --> 0:05:37.120
<v Speaker 3>for vaccinating, for creating a vaccine.

0:05:37.120 --> 0:05:43.560
<v Speaker 1>Until now, until now. The story of how we got

0:05:43.600 --> 0:05:46.880
<v Speaker 1>to the RSV vaccine starts in nineteen fifty six. That

0:05:47.040 --> 0:05:49.760
<v Speaker 1>was the year RSV was discovered, and as you may

0:05:49.839 --> 0:05:52.159
<v Speaker 1>remember from last week's show, that was just a year

0:05:52.240 --> 0:05:55.880
<v Speaker 1>after Jonas Salk's polio vaccine was approved to huge acclaim

0:05:56.360 --> 0:05:59.360
<v Speaker 1>and so naturally, a group of scientists started developing an

0:05:59.480 --> 0:06:02.920
<v Speaker 1>RSVV vaccine using the same technique that Saulk had used

0:06:02.920 --> 0:06:06.800
<v Speaker 1>for polio. The idea was to grow the virus, kill it,

0:06:07.080 --> 0:06:10.760
<v Speaker 1>and inject it into patients. By the mid nineteen sixties,

0:06:10.920 --> 0:06:13.960
<v Speaker 1>scientists were ready to launch a clinical trial of their

0:06:14.000 --> 0:06:17.560
<v Speaker 1>newly developed RSV vaccine, and they gave it to thirty

0:06:17.600 --> 0:06:21.520
<v Speaker 1>one children in Washington, DC. I talked about this with

0:06:21.600 --> 0:06:25.800
<v Speaker 1>Barney Graham. He's a virologist and he started studying RSV

0:06:26.160 --> 0:06:28.920
<v Speaker 1>at the National Institutes of Health in the nineteen eighties.

0:06:29.440 --> 0:06:32.760
<v Speaker 1>But that earlier work on RSV, that vaccine trial in

0:06:32.800 --> 0:06:35.919
<v Speaker 1>the nineteen sixties, it had a huge effect on Barney

0:06:35.960 --> 0:06:37.360
<v Speaker 1>and really on the whole field.

0:06:39.680 --> 0:06:43.640
<v Speaker 2>During that winter time of sixty six sixty seven, just

0:06:43.720 --> 0:06:48.200
<v Speaker 2>after Christmas, there was a big RSV outbreak that occurred,

0:06:49.160 --> 0:06:54.279
<v Speaker 2>and of the thirty one children who were immunized with

0:06:54.400 --> 0:06:58.920
<v Speaker 2>this vaccine, about I think twenty were infected, but of

0:06:58.960 --> 0:07:04.720
<v Speaker 2>those twenty sixteen required hospitization. Two of them died. So

0:07:04.839 --> 0:07:10.920
<v Speaker 2>it was a really catastrophic failure of the vaccine.

0:07:11.400 --> 0:07:13.600
<v Speaker 1>Just to be clear. So that study found that the

0:07:13.680 --> 0:07:18.200
<v Speaker 1>vaccine not only did it not protect children, it actually

0:07:19.560 --> 0:07:20.400
<v Speaker 1>made them sicker.

0:07:20.760 --> 0:07:24.480
<v Speaker 2>Yes, my first twenty years of research were really focused

0:07:24.520 --> 0:07:28.240
<v Speaker 2>almost entirely on trying to understand this problem so we

0:07:28.280 --> 0:07:31.880
<v Speaker 2>could get back to RSV vaccine development.

0:07:32.480 --> 0:07:35.000
<v Speaker 1>So what happened with that nineteen sixties vaccine trail? Why

0:07:35.040 --> 0:07:35.559
<v Speaker 1>did it fail?

0:07:36.160 --> 0:07:39.440
<v Speaker 2>So the vaccine that was made in the nineteen sixties,

0:07:40.120 --> 0:07:44.080
<v Speaker 2>the way that the vaccine was prepared changed the proteins

0:07:44.120 --> 0:07:48.040
<v Speaker 2>in a way that when that was used to immunize,

0:07:48.200 --> 0:07:52.320
<v Speaker 2>it created antibodies that could bind the virus but did

0:07:52.360 --> 0:07:55.720
<v Speaker 2>not block the virus or didn't prevent virus infection. And

0:07:55.800 --> 0:07:59.280
<v Speaker 2>so having a lot of antibody and a lot of

0:07:59.360 --> 0:08:03.760
<v Speaker 2>virus to get together without preventing infection can sometimes lead

0:08:04.200 --> 0:08:05.560
<v Speaker 2>to problems.

0:08:05.680 --> 0:08:08.400
<v Speaker 1>And in this instance, it did lead to problems.

0:08:08.560 --> 0:08:11.760
<v Speaker 2>Yes, it did lead to problems. And then what was

0:08:11.840 --> 0:08:17.160
<v Speaker 2>needed to make that vaccine work is having proteins that

0:08:17.280 --> 0:08:21.520
<v Speaker 2>could make better antibody responses and not so many ineffective

0:08:21.520 --> 0:08:22.720
<v Speaker 2>antibody responses.

0:08:24.840 --> 0:08:28.400
<v Speaker 1>When Barney says proteins there, he's talking in particular about

0:08:28.400 --> 0:08:31.400
<v Speaker 1>this one protein that sits on the outer surface of

0:08:31.440 --> 0:08:35.720
<v Speaker 1>the virus. That protein is important because our immune system

0:08:36.040 --> 0:08:40.000
<v Speaker 1>recognizes that protein and then creates matching antibodies to destroy

0:08:40.040 --> 0:08:43.679
<v Speaker 1>the virus. The proteins called the F protein or the

0:08:43.800 --> 0:08:48.240
<v Speaker 1>F glycoprotein. F stands for fusion because it's the protein

0:08:48.320 --> 0:08:50.880
<v Speaker 1>that the virus uses to fuse with the cell in

0:08:50.920 --> 0:08:54.360
<v Speaker 1>the human body, and Barney and his colleagues knew they

0:08:54.440 --> 0:08:57.000
<v Speaker 1>needed to crack the code of that F protein.

0:08:58.640 --> 0:09:02.600
<v Speaker 2>What I knew about the F protein on RSV was

0:09:02.600 --> 0:09:05.720
<v Speaker 2>that it was a blob on a western blot that

0:09:05.960 --> 0:09:09.760
<v Speaker 2>just looked like a black ink spot, and you could

0:09:09.840 --> 0:09:14.120
<v Speaker 2>tell what size it was, but you couldn't really see it.

0:09:14.200 --> 0:09:18.200
<v Speaker 2>You couldn't really understand how it was folded and how

0:09:18.240 --> 0:09:22.160
<v Speaker 2>it worked. If you want to make a vaccine, you

0:09:22.320 --> 0:09:25.640
<v Speaker 2>really need to see the protein and how it interacts

0:09:25.640 --> 0:09:29.280
<v Speaker 2>with the antibodies and the exact surface contours and the

0:09:29.360 --> 0:09:32.720
<v Speaker 2>exact shape of that protein. So if you want to

0:09:32.720 --> 0:09:35.439
<v Speaker 2>get a virus infection started, you have to figure out

0:09:35.440 --> 0:09:37.679
<v Speaker 2>a way to get the virus, you know, inside the

0:09:37.880 --> 0:09:40.600
<v Speaker 2>human cell in order for the virus to start growing.

0:09:41.640 --> 0:09:43.800
<v Speaker 2>And the way the virus does that it has this

0:09:44.880 --> 0:09:49.040
<v Speaker 2>interesting protein on its surface that is able to transform.

0:09:49.120 --> 0:09:53.800
<v Speaker 2>It is able to unravel, reach out, grab the host

0:09:53.920 --> 0:09:58.960
<v Speaker 2>cell or target cell membrane and pull the membranes back together,

0:09:59.200 --> 0:10:05.320
<v Speaker 2>so the host cell and the virus membrane fuse. They merged,

0:10:06.320 --> 0:10:09.679
<v Speaker 2>then the virus genome can enter the cell and start

0:10:09.720 --> 0:10:11.000
<v Speaker 2>the replication process.

0:10:11.080 --> 0:10:14.160
<v Speaker 1>I mean, that's the crucial bad thing that happens, right,

0:10:14.240 --> 0:10:15.760
<v Speaker 1>That's the thing we don't want to happen.

0:10:15.880 --> 0:10:18.720
<v Speaker 2>If you want to stop a virus infection, if you

0:10:18.800 --> 0:10:23.600
<v Speaker 2>can stop that F protein from rearranging or from attaching,

0:10:23.840 --> 0:10:28.480
<v Speaker 2>then you've got a good way of stopping the virus infection.

0:10:29.600 --> 0:10:34.679
<v Speaker 1>What did scientists not know about that F protein.

0:10:35.040 --> 0:10:37.960
<v Speaker 2>Well, the main thing we didn't know is why it

0:10:38.040 --> 0:10:40.560
<v Speaker 2>had not worked as a vaccine.

0:10:41.200 --> 0:10:43.880
<v Speaker 1>And what did you want to learn about the F

0:10:43.960 --> 0:10:46.040
<v Speaker 1>protein to try and solve that problem.

0:10:46.480 --> 0:10:49.240
<v Speaker 2>Well, we really wanted to know what the F protein

0:10:49.320 --> 0:10:53.440
<v Speaker 2>looked like in its original state. We wanted to know

0:10:54.040 --> 0:10:58.160
<v Speaker 2>where the antibodies could bind F protein and how what

0:10:58.400 --> 0:11:02.160
<v Speaker 2>was the mechanism for neutral the virus. And to understand

0:11:02.240 --> 0:11:04.920
<v Speaker 2>those things, we needed to know more about the structure

0:11:04.920 --> 0:11:08.679
<v Speaker 2>off not just in its final rearranged state, but in

0:11:08.720 --> 0:11:09.760
<v Speaker 2>its original state.

0:11:11.679 --> 0:11:15.240
<v Speaker 1>Barney's making a really key point right here that F

0:11:15.320 --> 0:11:18.800
<v Speaker 1>protein on the surface of rsv it exists in two

0:11:18.880 --> 0:11:21.800
<v Speaker 1>different shapes. It has one shape when the virus is

0:11:21.840 --> 0:11:24.080
<v Speaker 1>floating around in the body searching for a cell to

0:11:24.160 --> 0:11:27.640
<v Speaker 1>fuse with. Then when the virus fuses with the cell,

0:11:27.800 --> 0:11:31.440
<v Speaker 1>the F protein changes shape. So what our immune system

0:11:31.480 --> 0:11:34.840
<v Speaker 1>needs are antibodies to that F protein when it's in

0:11:34.880 --> 0:11:38.079
<v Speaker 1>its prefusion state, before it's fused with the cell in

0:11:38.120 --> 0:11:41.000
<v Speaker 1>our body. But when Barney and his colleagues were studying

0:11:41.040 --> 0:11:44.200
<v Speaker 1>the virus, they always saw the protein in the other shape,

0:11:44.320 --> 0:11:47.200
<v Speaker 1>in the post fusion shape. That problem went all the

0:11:47.200 --> 0:11:50.160
<v Speaker 1>way back to that failed vaccine in the nineteen sixties,

0:11:50.480 --> 0:11:52.440
<v Speaker 1>and it was a problem Barney was still trying to

0:11:52.440 --> 0:11:55.520
<v Speaker 1>solve in two thousand and eight. That's when Barney had

0:11:55.559 --> 0:11:58.680
<v Speaker 1>a chance meeting with the scientist who would finally solve

0:11:58.760 --> 0:12:01.520
<v Speaker 1>the puzzle that r s V researchers had been working

0:12:01.520 --> 0:12:04.040
<v Speaker 1>on for decades. Well, hear that part of the story

0:12:04.240 --> 0:12:15.120
<v Speaker 1>in just a minute. While Barney Graham was working way

0:12:15.240 --> 0:12:17.240
<v Speaker 1>trying to solve the puzzle of how to create a

0:12:17.280 --> 0:12:20.800
<v Speaker 1>vaccine for RSV, he met a guy named Jason McClellan,

0:12:21.040 --> 0:12:23.800
<v Speaker 1>who at the time was a research fellow who worked

0:12:23.840 --> 0:12:27.720
<v Speaker 1>just down the hall. I recently talked with Jason McClellan

0:12:27.840 --> 0:12:29.520
<v Speaker 1>and we started with the work he was doing when

0:12:29.520 --> 0:12:32.240
<v Speaker 1>he met Barney. While Barney had been studying the proteins

0:12:32.240 --> 0:12:35.560
<v Speaker 1>on the outside of RSV, Jason was studying the proteins

0:12:35.559 --> 0:12:39.160
<v Speaker 1>on the outside of a different virus, HIV. This was

0:12:39.200 --> 0:12:41.280
<v Speaker 1>back in two thousand and eight, and at the time

0:12:41.400 --> 0:12:43.600
<v Speaker 1>Jason told me he was working in a field called

0:12:43.720 --> 0:12:45.520
<v Speaker 1>structure based vaccine design.

0:12:46.760 --> 0:12:49.640
<v Speaker 4>It's really a trying to turn vaccine development into a

0:12:49.760 --> 0:12:54.200
<v Speaker 4>very rational engineering approach that's guided by the human immune system.

0:12:54.840 --> 0:12:57.400
<v Speaker 1>That word engineering is good, right, You're like actually trying

0:12:57.440 --> 0:13:01.000
<v Speaker 1>to build a thing in a certain shape exactly when

0:13:01.040 --> 0:13:04.040
<v Speaker 1>you so you joined this lab working on this idea

0:13:04.480 --> 0:13:08.160
<v Speaker 1>structure based vaccine design for HIV. There's this idea, Oh,

0:13:08.200 --> 0:13:10.800
<v Speaker 1>we have these new tools, we could we could build

0:13:10.880 --> 0:13:17.120
<v Speaker 1>vaccines in this new, potentially better way. Had anybody done

0:13:17.160 --> 0:13:17.520
<v Speaker 1>it yet?

0:13:18.760 --> 0:13:22.680
<v Speaker 4>No. That's really some of the pioneering efforts for structure

0:13:22.720 --> 0:13:27.880
<v Speaker 4>based vaccine design and its application to HIV, And it

0:13:27.960 --> 0:13:32.640
<v Speaker 4>quickly became a parent that we're developing really cool approaches,

0:13:33.040 --> 0:13:35.320
<v Speaker 4>but many of them aren't working, and it's unclear whether

0:13:35.360 --> 0:13:38.480
<v Speaker 4>the approaches aren't good or the virus is just so

0:13:38.600 --> 0:13:42.280
<v Speaker 4>difficult to make a vaccine for why don't we sort

0:13:42.280 --> 0:13:44.680
<v Speaker 4>of apply this to maybe a more tractable virus so

0:13:44.679 --> 0:13:49.080
<v Speaker 4>we could test some of these techniques. And I was

0:13:49.120 --> 0:13:50.920
<v Speaker 4>on a different floor from the rest of the lab.

0:13:50.960 --> 0:13:54.000
<v Speaker 4>I was actually in Barney Graham's floor, and Barney heard

0:13:54.040 --> 0:13:56.680
<v Speaker 4>of this and he was like, you know, RSV would

0:13:56.679 --> 0:13:59.640
<v Speaker 4>be perfect for applications of structure based vaccine design. So

0:14:00.480 --> 0:14:02.440
<v Speaker 4>for the next yeah, the rest of my time next

0:14:02.440 --> 0:14:04.680
<v Speaker 4>five years or so, I sort of split half my

0:14:04.720 --> 0:14:07.960
<v Speaker 4>time working on HIV and half my time working on RSB.

0:14:08.559 --> 0:14:10.640
<v Speaker 1>So this is a good guy for you to meet

0:14:10.720 --> 0:14:13.320
<v Speaker 1>at this moment. This is a good happy meeting in

0:14:13.320 --> 0:14:14.520
<v Speaker 1>this science.

0:14:14.160 --> 0:14:18.040
<v Speaker 4>Scenario, it's very fertuitous happy meeting. It was like December

0:14:18.040 --> 0:14:20.280
<v Speaker 4>two thousand and eight, when we had sort of formalized

0:14:20.280 --> 0:14:23.680
<v Speaker 4>the plan. We decided to start working on RSV in

0:14:23.720 --> 0:14:24.800
<v Speaker 4>structure based design.

0:14:25.240 --> 0:14:27.440
<v Speaker 1>At this moment, when you decide to do this, what's

0:14:27.480 --> 0:14:28.680
<v Speaker 1>the key thing you don't know?

0:14:30.240 --> 0:14:34.160
<v Speaker 4>So we know that the F protein exists in two confirmations.

0:14:33.720 --> 0:14:35.040
<v Speaker 1>Too, Does that mean two shapes?

0:14:35.480 --> 0:14:38.160
<v Speaker 4>Two shapes? Yeah, So they had been so it had

0:14:38.200 --> 0:14:42.160
<v Speaker 4>been imaged by electron microscopy, and it was clear that

0:14:42.240 --> 0:14:45.080
<v Speaker 4>one form looked like these elongated golf teas and the

0:14:45.160 --> 0:14:48.720
<v Speaker 4>other was sort of more oval, lollipop shaped with like

0:14:48.720 --> 0:14:51.760
<v Speaker 4>a little stock. And so it had become appreciated that

0:14:52.000 --> 0:14:55.480
<v Speaker 4>one of them was the prefusion confirmation, okay, and then

0:14:55.720 --> 0:14:57.480
<v Speaker 4>the other one is postfusion.

0:14:57.640 --> 0:15:00.840
<v Speaker 1>And so it's basically, before it's attached to this this

0:15:00.920 --> 0:15:03.160
<v Speaker 1>protein has one shape and after it's attached to the shell,

0:15:03.200 --> 0:15:04.000
<v Speaker 1>it has another shape.

0:15:04.160 --> 0:15:10.040
<v Speaker 4>Yeah, we were unable to make the prefusion state as

0:15:10.040 --> 0:15:13.960
<v Speaker 4>a purified protein. So if you just purify f it

0:15:14.040 --> 0:15:16.840
<v Speaker 4>sort of snaps into the postfusion state, which is the

0:15:16.880 --> 0:15:21.040
<v Speaker 4>lowest energy, most stable state, and people had immunized with that,

0:15:21.440 --> 0:15:23.920
<v Speaker 4>but it was insufficient to make a vaccine.

0:15:23.960 --> 0:15:27.120
<v Speaker 1>Well, and that makes sense at some level, right, because

0:15:27.600 --> 0:15:31.560
<v Speaker 1>what you actually want to immunize against is the prefusion shape.

0:15:31.640 --> 0:15:31.760
<v Speaker 4>Right.

0:15:31.800 --> 0:15:34.720
<v Speaker 1>The virus is floating around in our respiratory tract and

0:15:35.040 --> 0:15:37.240
<v Speaker 1>it's before it attaches to the cells, it's in the

0:15:37.280 --> 0:15:38.480
<v Speaker 1>prefusion shape.

0:15:38.520 --> 0:15:38.680
<v Speaker 3>Right.

0:15:38.680 --> 0:15:40.760
<v Speaker 1>What we really want is for our body to have

0:15:40.800 --> 0:15:43.360
<v Speaker 1>on the bodies to attack that. So if you're using

0:15:43.360 --> 0:15:46.160
<v Speaker 1>the postfusion state, it's intuitive that like that's not going

0:15:46.240 --> 0:15:47.320
<v Speaker 1>to work as well.

0:15:47.120 --> 0:15:51.080
<v Speaker 4>Right, Exactly, Our colleague Jose Malero in Spain. What he

0:15:51.200 --> 0:15:54.800
<v Speaker 4>showed was that most of the neutralizing antibodies did not

0:15:54.920 --> 0:15:59.800
<v Speaker 4>bind postfusion, suggesting that the majority of the antibodies humans

0:15:59.800 --> 0:16:04.120
<v Speaker 4>may in response to an RSV infection do not target posts.

0:16:04.280 --> 0:16:06.920
<v Speaker 1>And we have the problem that it's hard to isolate

0:16:06.960 --> 0:16:09.200
<v Speaker 1>pre we don't know exactly what it looks like, like,

0:16:09.240 --> 0:16:11.080
<v Speaker 1>this is the this is the problem, right.

0:16:11.040 --> 0:16:15.640
<v Speaker 4>Yeah, So we assumed that from Hose's data that there

0:16:15.640 --> 0:16:20.040
<v Speaker 4>are antibodies that bind only to prefusion. So we thought

0:16:20.080 --> 0:16:25.040
<v Speaker 4>that if we could isolate some antibodies like this, we

0:16:25.080 --> 0:16:27.840
<v Speaker 4>could make F protein in the presence of these antibodies,

0:16:28.360 --> 0:16:33.600
<v Speaker 4>and when F transiently adopts prefusion, the antibody binds and

0:16:33.640 --> 0:16:37.119
<v Speaker 4>locks it, and then we'd be able to purify that complex.

0:16:37.520 --> 0:16:42.000
<v Speaker 1>That's very clever. So you're using the body's own response

0:16:42.120 --> 0:16:46.240
<v Speaker 1>to the prefusion protein, the antibodies to basically make a

0:16:46.280 --> 0:16:51.920
<v Speaker 1>trap for the prefusion protein. Exactly In the lab, Jason

0:16:52.000 --> 0:16:55.000
<v Speaker 1>runs an experiment to do just this. He takes an

0:16:55.200 --> 0:16:59.120
<v Speaker 1>F protein in that prefusion shape, that lollipop shape, and

0:16:59.160 --> 0:17:02.720
<v Speaker 1>then he binds the protein to an antibody, and once

0:17:02.760 --> 0:17:05.920
<v Speaker 1>the F protein is bound to the antibody. The protein

0:17:06.080 --> 0:17:09.520
<v Speaker 1>cannot change its shape. So now Jason has the F

0:17:09.560 --> 0:17:12.800
<v Speaker 1>protein locked in place in the right shape, and he

0:17:12.880 --> 0:17:16.440
<v Speaker 1>needs to see exactly what it looks like. To do that,

0:17:16.760 --> 0:17:20.400
<v Speaker 1>he uses a technique called xtray crystallography, which lets him

0:17:20.440 --> 0:17:23.639
<v Speaker 1>see the shape of the protein in incredible detail. He

0:17:23.680 --> 0:17:28.000
<v Speaker 1>can see the atomic level structure of this prefusion F protein,

0:17:28.560 --> 0:17:31.680
<v Speaker 1>and Jason knew this was a very big deal.

0:17:33.440 --> 0:17:37.800
<v Speaker 4>It was going to allow us to make prefusion.

0:17:37.280 --> 0:17:39.520
<v Speaker 1>F okay to use as a vaccine.

0:17:39.680 --> 0:17:40.000
<v Speaker 2>Aha.

0:17:40.400 --> 0:17:43.560
<v Speaker 1>Right, So you can make the exact thing as it

0:17:43.600 --> 0:17:48.200
<v Speaker 1>exists on the surface of an RSV cell and put

0:17:48.240 --> 0:17:52.159
<v Speaker 1>it into people's bodies in some fashion, and you'll have

0:17:52.240 --> 0:17:55.359
<v Speaker 1>the perfect protein. You'll have the exact shape of the protein,

0:17:55.400 --> 0:17:59.440
<v Speaker 1>and the body will make these great antibodies and that

0:17:59.480 --> 0:18:02.439
<v Speaker 1>body don't get sick with RSV if everything goes according

0:18:02.480 --> 0:18:03.720
<v Speaker 1>to plan exactly right.

0:18:03.760 --> 0:18:06.239
<v Speaker 4>It's like, I don't know, we're sculptors, and now we

0:18:06.280 --> 0:18:08.240
<v Speaker 4>have the model of what we need to make the

0:18:08.280 --> 0:18:11.440
<v Speaker 4>sculpture of and it allows us to make ideal mimics

0:18:11.680 --> 0:18:14.080
<v Speaker 4>of these proteins found on the surface of the virus.

0:18:14.280 --> 0:18:18.560
<v Speaker 1>Amazing. So at this at this moment, do you feel

0:18:18.560 --> 0:18:25.480
<v Speaker 1>like you've got it, Like you feel like you yet Yeah, okay,

0:18:25.800 --> 0:18:27.960
<v Speaker 1>what has to happen when we're very excited?

0:18:27.960 --> 0:18:30.879
<v Speaker 4>We have pre F, but we we have not been

0:18:30.920 --> 0:18:33.720
<v Speaker 4>able to produce it in the absence of those antibodies

0:18:33.760 --> 0:18:36.800
<v Speaker 4>the camp it okay, right, So that's the key. We

0:18:36.880 --> 0:18:40.280
<v Speaker 4>have to modify the F protein such that when we

0:18:40.440 --> 0:18:44.359
<v Speaker 4>express it in cells in the absence of antibodies, it

0:18:44.480 --> 0:18:48.159
<v Speaker 4>folds into PREF, stays in pre F, and allows us

0:18:48.200 --> 0:18:49.000
<v Speaker 4>to immunize with it.

0:18:49.600 --> 0:18:52.119
<v Speaker 1>So you have to kind of build a version of

0:18:52.160 --> 0:18:56.840
<v Speaker 1>it from scratch. Now that'll work in this very particular

0:18:56.880 --> 0:18:59.159
<v Speaker 1>way that it has to work for you're going to

0:18:59.200 --> 0:19:00.440
<v Speaker 1>make a vaccine, right.

0:19:00.640 --> 0:19:05.720
<v Speaker 4>I designed several substitutions that ended up working. Four of

0:19:05.760 --> 0:19:10.800
<v Speaker 4>them in combination allowed the prefusion F protein to be

0:19:11.160 --> 0:19:12.439
<v Speaker 4>expressed and purified.

0:19:12.560 --> 0:19:16.160
<v Speaker 1>And this is more sculpting, right, literally like filling holes

0:19:16.200 --> 0:19:18.640
<v Speaker 1>in the shape of the protein, right, Yeah.

0:19:18.480 --> 0:19:20.800
<v Speaker 4>Because the structure tells us, oh, there's some pockets and

0:19:20.800 --> 0:19:24.280
<v Speaker 4>cavities here that are causing instability, so why don't we

0:19:24.359 --> 0:19:24.880
<v Speaker 4>fill them?

0:19:25.560 --> 0:19:28.800
<v Speaker 1>You're really building this physical thing in a particular way.

0:19:29.000 --> 0:19:32.080
<v Speaker 4>Yeah, yeah, very specifically. So we have we have like

0:19:32.119 --> 0:19:36.200
<v Speaker 4>almost an atomic level mimic. And then the next step

0:19:36.359 --> 0:19:39.040
<v Speaker 4>was to make those proteins and provide them to Barney

0:19:39.040 --> 0:19:42.920
<v Speaker 4>Graham's lab. And so Barney then immunized mice and then

0:19:43.000 --> 0:19:45.439
<v Speaker 4>blood was drawn from the mice and they'd performed the

0:19:45.520 --> 0:19:49.800
<v Speaker 4>neutralization essays. And then that was the exciting day. That's

0:19:49.840 --> 0:19:53.600
<v Speaker 4>when because Barney told me it's he couldn't believe it. It

0:19:53.640 --> 0:19:57.000
<v Speaker 4>was the highest neutralizing antibody tighters he had ever seen

0:19:57.240 --> 0:19:59.360
<v Speaker 4>in his decades of working on RSV.

0:20:00.160 --> 0:20:05.600
<v Speaker 1>Meaning the best, right, yeah, it listened, the strongest response. Yeah.

0:20:05.600 --> 0:20:07.960
<v Speaker 4>And so at that point we're like, we got it,

0:20:08.119 --> 0:20:10.720
<v Speaker 4>Like this, this is exactly what we were looking for,

0:20:11.200 --> 0:20:14.760
<v Speaker 4>this proof of concept for structure based vaccine design.

0:20:15.680 --> 0:20:23.720
<v Speaker 1>So now in twenty twenty three, these RSV vaccines based

0:20:23.760 --> 0:20:27.080
<v Speaker 1>on your research are are coming out. They're a thing

0:20:27.080 --> 0:20:30.719
<v Speaker 1>in the world, and millions of people presumably are getting

0:20:30.720 --> 0:20:33.520
<v Speaker 1>this vaccine, are about to get this vaccine. I mean,

0:20:33.520 --> 0:20:36.160
<v Speaker 1>what's that like for you? That's amazing.

0:20:38.359 --> 0:20:41.520
<v Speaker 4>That always wanted to try to have some impact improve

0:20:41.560 --> 0:20:43.960
<v Speaker 4>people's lives, and you know, you know, it's sort of

0:20:44.000 --> 0:20:46.720
<v Speaker 4>a long shot to actually help make a vaccine, just

0:20:46.760 --> 0:20:50.919
<v Speaker 4>given how few vaccines get approved but to actually do

0:20:51.000 --> 0:20:53.159
<v Speaker 4>it is I mean, it's credible. It's everything you can

0:20:53.240 --> 0:20:53.640
<v Speaker 4>hope for.

0:20:55.359 --> 0:20:58.240
<v Speaker 1>There is one more piece of the Jason and Barney

0:20:58.280 --> 0:21:03.120
<v Speaker 1>story that's worth telling before we go. In twenty twelve,

0:21:03.200 --> 0:21:06.080
<v Speaker 1>there was an outbreak of a new disease in Saudi Arabia.

0:21:06.480 --> 0:21:09.320
<v Speaker 1>The disease was caused by a coronavirus, and it was

0:21:09.359 --> 0:21:14.200
<v Speaker 1>given the name MERZ for Middle Eastern Respiratory syndrome. Jason

0:21:14.240 --> 0:21:17.480
<v Speaker 1>and Barney went to work on that coronavirus. Using the

0:21:17.600 --> 0:21:21.440
<v Speaker 1>engineering and structural biology techniques they'd honed in their work

0:21:21.480 --> 0:21:25.639
<v Speaker 1>on RSV. They developed an incredibly detailed picture of the

0:21:25.680 --> 0:21:29.840
<v Speaker 1>prefusion spike protein. They did that sculpting works to create

0:21:29.880 --> 0:21:33.960
<v Speaker 1>a stable version of that protein, and they did preliminary

0:21:34.000 --> 0:21:39.199
<v Speaker 1>work toward developing a vaccine. Then, in twenty nineteen, another

0:21:39.280 --> 0:21:43.680
<v Speaker 1>new coronavirus emerged, the virus that causes COVID. This time,

0:21:43.960 --> 0:21:46.720
<v Speaker 1>Jason and Barney were ready. The work they had done

0:21:46.720 --> 0:21:50.359
<v Speaker 1>first on RSV then on MERZ meant that just a

0:21:50.400 --> 0:21:53.720
<v Speaker 1>few weeks after that new virus was discovered, they were

0:21:53.760 --> 0:21:57.040
<v Speaker 1>able to create a stabilized version of that key spike

0:21:57.080 --> 0:22:00.439
<v Speaker 1>protein in just the right shape that work played a

0:22:00.480 --> 0:22:04.440
<v Speaker 1>major role in designing the COVID nineteen vaccines. The protein

0:22:04.480 --> 0:22:06.600
<v Speaker 1>they created was one of the key reasons it was

0:22:06.680 --> 0:22:12.840
<v Speaker 1>possible for the vaccines to be developed so quickly. Thanks

0:22:12.840 --> 0:22:16.760
<v Speaker 1>to my guests today Karen Lanman, Arnie Graham, and Jason McClellan.

0:22:17.840 --> 0:22:21.280
<v Speaker 1>Next week on Incubation, the story of the Common Cold Unit,

0:22:21.600 --> 0:22:25.480
<v Speaker 1>a place where tens of thousands of people went voluntarily

0:22:25.600 --> 0:22:30.640
<v Speaker 1>for decades to catch a cold. You know, Britain post war.

0:22:31.359 --> 0:22:33.679
<v Speaker 1>Chimpanzees are not easy to come by to do this

0:22:33.760 --> 0:22:37.160
<v Speaker 1>type of research, So what's definitely the next best thing

0:22:37.320 --> 0:22:43.240
<v Speaker 1>are human volunteers, so human guinea pigs. Incubation is a

0:22:43.240 --> 0:22:47.040
<v Speaker 1>co production of Pushkin Industries and Ruby Studio at iHeartMedia.

0:22:47.359 --> 0:22:50.720
<v Speaker 1>It's produced by Gabriel Hunter Chang, Ariela Markowitz and Amy

0:22:50.800 --> 0:22:55.440
<v Speaker 1>Gaines McQuaid. Our editors are Julia Barton and Karen Schakerjie

0:22:55.480 --> 0:22:59.119
<v Speaker 1>Mastering by Anne Pope, fact checking by Joseph Fridman. Our

0:22:59.160 --> 0:23:03.520
<v Speaker 1>executive producers are Katherine Girardeau and Matt Romano. I'm Jacob Goldstein.

0:23:03.720 --> 0:23:04.479
<v Speaker 1>Thanks for listening.